1. Home
  2. FKWL vs RNXT Comparison

FKWL vs RNXT Comparison

Compare FKWL & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Wireless Corp.

FKWL

Franklin Wireless Corp.

HOLD

Current Price

$3.48

Market Cap

44.7M

Sector

Utilities

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.88

Market Cap

37.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FKWL
RNXT
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.7M
37.0M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
FKWL
RNXT
Price
$3.48
$0.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$8.25
AVG Volume (30 Days)
7.9K
279.1K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
1.10%
N/A
EPS Growth
94.12
20.00
EPS
0.10
N/A
Revenue
$46,086,901.00
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
$7.14
$279.78
P/E Ratio
$34.80
N/A
Revenue Growth
49.65
2511.63
52 Week Low
$3.41
$0.70
52 Week High
$5.48
$1.45

Technical Indicators

Market Signals
Indicator
FKWL
RNXT
Relative Strength Index (RSI) 35.28 43.34
Support Level N/A $0.81
Resistance Level $4.47 $1.07
Average True Range (ATR) 0.08 0.06
MACD -0.02 -0.00
Stochastic Oscillator 5.26 40.00

Price Performance

Historical Comparison
FKWL
RNXT

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: